-
1
-
-
77954931491
-
Analgesic effects of substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker
-
Abbadie, C., McManus, O. B., Sun, S.-Y., Bugianesi, R. M., Dai, G., Haedo, R. J., Herrington, J. B., Kaczorowski, Smith, M. M., Swensen, A. M., Warren, V. A., Williams, B., Arneric, S. P., Eduljee, C., Snutch, T. P., Tringha, E. W., Jochnowitz, N., Liang, A., MacIntyre, D. E., McGowan, E., Mistry, S., White, V. V., Hoyt, S. B., London, C., Lyons, K. A., Bunting, P. B., Volksdorf, S., and Duffy, J. L. (2010). Analgesic effects of substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. J. Pharmcol. Exp. Ther. 334, 545-555.
-
(2010)
J. Pharmcol. Exp. Ther.
, vol.334
, pp. 545-555
-
-
Abbadie, C.1
McManus, O.B.2
Sun, S.-Y.3
Bugianesi, R.M.4
Dai, G.5
Haedo, R.J.6
Herrington, J.B.7
Kaczorowski8
Smith, M.M.9
Swensen, A.M.10
Warren, V.A.11
Williams, B.12
Arneric, S.P.13
Eduljee, C.14
Snutch, T.P.15
Tringha, E.W.16
Jochnowitz, N.17
Liang, A.18
MacIntyre, D.E.19
McGowan, E.20
Mistry, S.21
White, V.V.22
Hoyt, S.B.23
London, C.24
Lyons, K.A.25
Bunting, P.B.26
Volksdorf, S.27
Duffy, J.L.28
more..
-
2
-
-
0020624782
-
Lidocaine block of sodium channels
-
Bean, B. P., Cohen, C. J., and Tsien, R. W. (1983). Lidocaine block of sodium channels. J. Gen. Physiol. 81, 613-642.
-
(1983)
J. Gen. Physiol.
, vol.81
, pp. 613-642
-
-
Bean, B.P.1
Cohen, C.J.2
Tsien, R.W.3
-
3
-
-
77953405501
-
Smallmolecule modulators of inward rectifier K+ channels: recent advances and future possibilities
-
Bhave, G., Lonergan, D., Chauder, B. A. II., and Denton, J. S. (2010). Smallmolecule modulators of inward rectifier K+ channels: recent advances and future possibilities. Future Med. Chem. 2, 757-774.
-
(2010)
Future Med. Chem.
, vol.2
, pp. 757-774
-
-
Bhave, G.1
Lonergan, D.2
Chauder, B.A.3
Denton II., J.S.4
-
4
-
-
76749151845
-
Prediction of drug-induced cardiotoxicity using human embryonic stem cellderived cardiomyocytes
-
Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., andMummery, C. L. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cellderived cardiomyocytes. Stem Cell Res. 4, 107-116.
-
(2010)
Stem Cell Res
, vol.4
, pp. 107-116
-
-
Braam, S.R.1
Tertoolen, L.2
van de Stolpe, A.3
Meyer, T.4
Passier, R.5
Mummery, C.L.6
-
5
-
-
0037198957
-
Molecular cloning, distribution and functional analysis of the Na(V)1.6. voltage-gated sodium channel from human brain
-
Burbidge, S. A., Dale, T. J., Powell, A. J., Whitaker, W. R., Xie, X. M., Romanos, M. A., and Clare, J. J. (2002). Molecular cloning, distribution and functional analysis of the Na(V)1.6. voltage-gated sodium channel from human brain. Brain Res. Mol. Brain Res. 103, 80-90.
-
(2002)
Brain Res. Mol Brain Res.
, vol.103
, pp. 80-90
-
-
Burbidge, S.A.1
Dale, T.J.2
Powell, A.J.3
Whitaker, W.R.4
Xie, X.M.5
Romanos, M.A.6
Clare, J.J.7
-
7
-
-
62649108973
-
Use of planar array electrophysiology for the development of robust ion channel cell lines
-
Clare, J. J., Chen, M. X., Downie, D. L., Trezise, D. J., and Powell, A. J. (2009). Use of planar array electrophysiology for the development of robust ion channel cell lines. Comb. Chem. High Throughput Screen. 12, 96-106.
-
(2009)
Comb. Chem. High Throughput Screen.
, vol.12
, pp. 96-106
-
-
Clare, J.J.1
Chen, M.X.2
Downie, D.L.3
Trezise, D.J.4
Powell, A.J.5
-
8
-
-
77955324516
-
Novel structure-activity relationships and selectivity profiling of cage dimeric 1 4-dihydropyridines as multidrug resistance (MDR) modulators
-
Coburger, C., Wollmann, J., Krug, M., Baumert, C., Seifert, M., Molnár, J., Lage, H., and Hilgeroth, A. (2010). Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Bioorg. Med. Chem. 18, 4983-4990.
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 4983-4990
-
-
Coburger, C.1
Wollmann, J.2
Krug, M.3
Baumert, C.4
Seifert, M.5
Molnár, J.6
Lage, H.7
Hilgeroth, A.8
-
9
-
-
43449137258
-
A highthroughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors
-
Dai, G., Haedo, R. J., Warren, V. A., Ratliff, K. S., Bugianesi, R. M., Rush, A., Williams, M. Herrington, JJ., Smith, M. M., McMann, O. B., and Swensen, A. M. (2008). A highthroughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors. Assay Drug Dev. Technol. 6, 195-212.
-
(2008)
Assay Drug Dev. Technol.
, vol.6
, pp. 195-212
-
-
Dai, G.1
Haedo, R.J.2
Warren, V.A.3
Ratliff, K.S.4
Bugianesi, R.M.5
Rush, A.6
Williams, M.7
Herrington, J.J.8
Smith, M.M.9
McMann, O.B.10
Swensen, A.M.11
-
10
-
-
4043083603
-
Functional assay of voltage-gated sodium channels usingmembrane potentialsensitive dyes
-
Felix, J. P., Williams, B. S., Priest, B. T., Brochu, R. M., Dick, I. E., Warren, V. A., Yan, L., Slaughter, R. S., Kaczorowski, G. J., Smith, M. M., and Garcia, M. L. (2004). Functional assay of voltage-gated sodium channels usingmembrane potentialsensitive dyes. Assay Drug Dev. Technol. 2, 260-268.
-
(2004)
Assay Drug Dev. Technol.
, vol.2
, pp. 260-268
-
-
Felix, J.P.1
Williams, B.S.2
Priest, B.T.3
Brochu, R.M.4
Dick, I.E.5
Warren, V.A.6
Yan, L.7
Slaughter, R.S.8
Kaczorowski, G.J.9
Smith, M.M.10
Garcia, M.L.11
-
11
-
-
0038471102
-
The impact of drug-induced QT interval prolongation on drug discovery and development
-
Fermini, B., and Fossa, A. A. (2003). The impact of drug-induced QT interval prolongation on drug discovery and development. Nat. Rev. Drug Discov. 2, 439-447.
-
(2003)
Nat. Rev. Drug Discov.
, vol.2
, pp. 439-447
-
-
Fermini, B.1
Fossa, A.A.2
-
12
-
-
34547869800
-
Highconductance calcium-activated potassium channels: validated targets for smoothmuscle relaxants?
-
Garcia, M. L., Shen, D.-M., and Kaczorowski, G. J. (2007). Highconductance calcium-activated potassium channels: validated targets for smoothmuscle relaxants? Expert Opin. Ther. Pat. 17, 1-12.
-
(2007)
Expert Opin Ther. Pat.
, vol.17
, pp. 1-12
-
-
Garcia, M.L.1
Shen, D.-M.2
Kaczorowski, G.J.3
-
13
-
-
82355169061
-
A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat
-
Herman, E. H., Knapton, A., Rosen, E., Thompson, K., Rosenzweig, B., Estis, J., Agee, S., Lu, Q. A., Todd, J. A., Lipshultz, S., Hasinoff, B., and Zhang, J. (2011). A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat. Toxicol. Pathol. 39, 1091-1106.
-
(2011)
Toxicol. Pathol.
, vol.39
, pp. 1091-1106
-
-
Herman, E.H.1
Knapton, A.2
Rosen, E.3
Thompson, K.4
Rosenzweig, B.5
Estis, J.6
Agee, S.7
Lu, Q.A.8
Todd, J.A.9
Lipshultz, S.10
Hasinoff, B.11
Zhang, J.12
-
14
-
-
74949143771
-
Inwardly rectifying potassium channels: their structure, function, and physiological roles
-
Hibino, H., Inanobe, A., Furutani, K., Murakami, S., Findlay, I., and Kurachi, Y. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 90, 291-366.
-
(2010)
Physiol. Rev.
, vol.90
, pp. 291-366
-
-
Hibino, H.1
Inanobe, A.2
Furutani, K.3
Murakami, S.4
Findlay, I.5
Kurachi, Y.6
-
15
-
-
0017726385
-
Time- and voltagedependent interactions of antiarrythmic drugs with cardiac sodium channels
-
Hondeghem, L. M., and Katzung, B. G. (1977). Time- and voltagedependent interactions of antiarrythmic drugs with cardiac sodium channels. Biochem. Biophys. Acta 472, 373-398.
-
(1977)
Biochem. Biophys. Acta
, vol.472
, pp. 373-398
-
-
Hondeghem, L.M.1
Katzung, B.G.2
-
16
-
-
17044424224
-
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2
-
Hong, K., Bjerregaard, P., Gussak, I., and Brugada, R. (2005). Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J. Cardiovasc. Electrophysiol. 16, 394-396.
-
(2005)
J. Cardiovasc. Electrophysiol
, vol.16
, pp. 394-396
-
-
Hong, K.1
Bjerregaard, P.2
Gussak, I.3
Brugada, R.4
-
17
-
-
42949108787
-
Ion channels as drug targets: the next GPCRs
-
Kaczorowski, G. J., McManus, O. B., Priest, B.T.,and Garcia, M. L. (2008). Ion channels as drug targets: the next GPCRs. J. Gen. Physiol. 131, 399-405.
-
(2008)
J. Gen. Physiol.
, vol.131
, pp. 399-405
-
-
Kaczorowski, G.J.1
McManus, O.B.2
Priest, B.T.3
Garcia, M.L.4
-
18
-
-
39749149703
-
A genetic framework for improving arrhythmia therapy
-
Knollmann, B. C., and Roden, D. M. (2008). A genetic framework for improving arrhythmia therapy. Nature 451, 929-936.
-
(2008)
Nature
, vol.451
, pp. 929-936
-
-
Knollmann, B.C.1
Roden, D.M.2
-
19
-
-
79955844082
-
Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes
-
Lin, Y. L., Hsiao, C. L., Wu, Y. C., and Kung, M. F. (2011). Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes. J. Clin. Pharmacol. 51, 819-829.
-
(2011)
J. Clin. Pharmacol.
, vol.51
, pp. 819-829
-
-
Lin, Y.L.1
Hsiao, C.L.2
Wu, Y.C.3
Kung, M.F.4
-
20
-
-
48149084580
-
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
-
Lu, H. R., Vlaminckx, E., Hermans, A. N., Rohrbacher, J., Van Ammel, K., Towart, R., Pugsley, M., and Gallacher, D. J. (2008). Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines. Br. J. Pharmacol. 154, 1427-1438.
-
(2008)
Br. J. Pharmacol.
, vol.154
, pp. 1427-1438
-
-
Lu, H.R.1
Vlaminckx, E.2
Hermans, A.N.3
Rohrbacher, J.4
Van Ammel, K.5
Towart, R.6
Pugsley, M.7
Gallacher, D.J.8
-
21
-
-
33645780149
-
QPatch: the past, present and future of automated patch clamp
-
Mathes, C. (2006). QPatch: the past, present and future of automated patch clamp. Expert Opin. Ther. Targets 10, 319-327.
-
(2006)
Expert Opin. Ther. Targets
, vol.10
, pp. 319-327
-
-
Mathes, C.1
-
22
-
-
33751527644
-
Innovative approaches to antiarrhythmic drug therapy
-
Nattel, S., and Carlsson, L. (2006). Innovative approaches to antiarrhythmic drug therapy. Nat. Rev. 5, 1034-1049.
-
(2006)
Nat. Rev.
, vol.5
, pp. 1034-1049
-
-
Nattel, S.1
Carlsson, L.2
-
23
-
-
77952554233
-
To the editor-market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006
-
Olsson, G. (2010). To the editor-market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006. Heart Rhythm 7, 864.
-
(2010)
Heart Rhythm
, vol.7
, pp. 864
-
-
Olsson, G.1
-
24
-
-
77950361453
-
KCNH2 pharmacogenomics summary
-
Oshiro, C., Thorn, C. F., Roden, D. M., Klein, T. E., and Altman, R. B. (2010). KCNH2 pharmacogenomics summary. Pharmacogenet. Genomics 20, 775-777.
-
(2010)
Pharmacogenet. Genomics
, vol.20
, pp. 775-777
-
-
Oshiro, C.1
Thorn, C.F.2
Roden, D.M.3
Klein, T.E.4
Altman, R.B.5
-
25
-
-
18344395134
-
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
-
Pargellis, C., Tong, L., Churchill, L., Cirrilo, P. F., Gilmore, T., Graham, A. G., Grob, P. M., Hickey, E. R., Moss, N. Pav, S., and Regan, J. (2002). Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9, 268-272.
-
(2002)
Nat. Struct. Biol.
, vol.9
, pp. 268-272
-
-
Pargellis, C.1
Tong, L.2
Churchill, L.3
Cirrilo, P.F.4
Gilmore, T.5
Graham, A.G.6
Grob, P.M.7
Hickey, E.R.8
Moss, N.9
Pav, S.10
Regan, J.11
-
26
-
-
77952292876
-
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
-
Peng, S., Lacerda, A. E., Kirsch, G. E., Brown, A. M., and Bruening-Wright, A. (2010). The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J. Pharmacol. Toxicol. Methods 61, 277-286.
-
(2010)
J. Pharmacol. Toxicol. Methods
, vol.61
, pp. 277-286
-
-
Peng, S.1
Lacerda, A.E.2
Kirsch, G.E.3
Brown, A.M.4
Bruening-Wright, A.5
-
27
-
-
80053588007
-
Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance
-
Raehal, K. M., Schmid, C. L., Groer, C. E., and Bohn, L. M. (2011). Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol. Rev. 63, 1001-1019.
-
(2011)
Pharmacol. Rev.
, vol.63
, pp. 1001-1019
-
-
Raehal, K.M.1
Schmid, C.L.2
Groer, C.E.3
Bohn, L.M.4
-
28
-
-
0344492207
-
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
-
Redfern, W., Carlsson, L., and Davis, A. S., Lynch, W. G., MacKenzie, I., Palethorpe, S., Siegl, P. K. S., Strang, I., Sullivan, A. T., Wallis, R., Camm, A. J., and Hammond, T. G. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32-45.
-
(2003)
Cardiovasc. Res.
, vol.58
, pp. 32-45
-
-
Redfern, W.1
Carlsson, L.2
Davis, A.S.3
Lynch, W.G.4
MacKenzie, I.5
Palethorpe, S.6
Siegl, P.K.S.7
Strang, I.8
Sullivan, A.T.9
Wallis, R.10
Camm, A.J.11
Hammond, T.G.12
-
29
-
-
0036200496
-
Cardiac ion channels
-
Roden, D. M., Balser, J. R., George, A. L., andAnderson, M. E. (2002). Cardiac ion channels. Annu. Rev. Physiol. 64, 431.
-
(2002)
Annu. Rev. Physiol.
, vol.64
, pp. 431
-
-
Roden, D.M.1
Balser, J.R.2
George, A.L.3
Anderson, M.E.4
-
30
-
-
1442306232
-
Drug-induced prolongation of the QT interval
-
Roden, D. M. (2004). Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350, 1013-1022.
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 1013-1022
-
-
Roden, D.M.1
-
31
-
-
80052274158
-
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
-
Rudolph, U., and Knoflach, F. (2011). Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat. Rev. Drug Discov. 10, 685-697.
-
(2011)
Nat. Rev. Drug Discov.
, vol.10
, pp. 685-697
-
-
Rudolph, U.1
Knoflach, F.2
-
32
-
-
84874948346
-
-
Available at
-
Sanofi Aventis. (2011). Available at: http://online.wsj.com/article/BT-CO -20110215-704422.html
-
(2011)
-
-
Aventis, S.1
-
33
-
-
54349114035
-
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors
-
Schmalhofer, W., Calhoun, J., Burrows, R., Bailey, T., Kohler, M. G., Weinglass, A. B., Kaczorowski, G. J., Garcia, M. L., Koltzenburg, M., and Priest, B. T. (2008). ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors. Mol. Pharmacol. 74, 1476-1484.
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 1476-1484
-
-
Schmalhofer, W.1
Calhoun, J.2
Burrows, R.3
Bailey, T.4
Kohler, M.G.5
Weinglass, A.B.6
Kaczorowski, G.J.7
Garcia, M.L.8
Koltzenburg, M.9
Priest, B.T.10
-
34
-
-
78650496072
-
A pharmacologically validated, high capacity, functional thallium flux assay for the herg channel
-
Schmalhofer, W. A., Swensen, A., Williams, B. S., Felix, J. P., Haedo, R., Solly, K., Kiss, L., Kaczorowski, G. J., and Garcia, M. L. (2010). A pharmacologically validated, high capacity, functional thallium flux assay for the herg channel. Assay Drug Dev. Technol. 8, 714-726.
-
(2010)
Assay Drug Dev. Technol.
, vol.8
, pp. 714-726
-
-
Schmalhofer, W.A.1
Swensen, A.2
Williams, B.S.3
Felix, J.P.4
Haedo, R.5
Solly, K.6
Kiss, L.7
Kaczorowski, G.J.8
Garcia, M.L.9
-
35
-
-
49249134845
-
Automated patch-clamp technique: increased throughput in functional characterization and in pharmacological screening of smallconductance Ca2+ release-activated Ca2+ channels
-
Schrøder, R. L., Friis, S., Sunesen, M., Mathes, C., and Willumsen, N. J. (2008). Automated patch-clamp technique: increased throughput in functional characterization and in pharmacological screening of smallconductance Ca2+ release-activated Ca2+ channels. J. Biomol. Screen 13, 638-647.
-
(2008)
J. Biomol. Screen
, vol.13
, pp. 638-647
-
-
Schrøder, R.L.1
Friis, S.2
Sunesen, M.3
Mathes, C.4
Willumsen, N.J.5
-
36
-
-
33749027737
-
Can pharmacogenetics help rescue drugs withdrawn fromthe market?
-
Shah, R. R. (2006). Can pharmacogenetics help rescue drugs withdrawn fromthe market? Pharmacogenomics 7, 889-908.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 889-908
-
-
Shah, R.R.1
-
37
-
-
80052204248
-
Identifying R&D outliers
-
Tollman, P., Morieux, Y., Murphy, J. K., and Schulze, U. (2011). Identifying R&D outliers. Nat. Rev. Drug Discov. 10, 653-654.
-
(2011)
Nat. Rev. Drug Discov
, vol.10
, pp. 653-654
-
-
Tollman, P.1
Morieux, Y.2
Murphy, J.K.3
Schulze, U.4
-
38
-
-
41149097657
-
Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake
-
Weinglass, A. B., Köhler, M. G., Nketiah, E. O., Liu, J., Schmalhofer, W., Thomas, A., Williams, B., Beers, L., Smith, L., Hafey, M., Bleasby, K., Leone, J., Tang, Y. S., Braun, M., Ujjainwalla, F., McCann, M. E., Kaczorowski, G. J., and Garcia, M. L. (2008a). Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake. Mol. Pharmacol. 73, 1072-8473.
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 1072-8473
-
-
Weinglass, A.B.1
Köhler, M.G.2
Nketiah, E.O.3
Liu, J.4
Schmalhofer, W.5
Thomas, A.6
Williams, B.7
Beers, L.8
Smith, L.9
Hafey, M.10
Bleasby, K.11
Leone, J.12
Tang, Y.S.13
Braun, M.14
Ujjainwalla, F.15
McCann, M.E.16
Kaczorowski, G.J.17
Garcia, M.L.18
-
39
-
-
49649125654
-
Extracellular loop C of NPC1L1 is important for binding to ezetimibe
-
Weinglass, A. B., Kohler, M., Schulte, U., Liu, J., Nketiah, E. O., Thomas, A., Schmalhofer, W., Williams, B., Bildl, W., McMasters, D. R., Dai, K., Beers, L., McCann, M. E., Kaczorowski, G. J., and Garcia, M. L. (2008b). Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc. Natl. Acad. Sci. U.S.A. 105, 11140-11145.
-
(2008)
Proc. Natl. Acad. Sci. U. S. A.
, vol.105
, pp. 11140-11145
-
-
Weinglass, A.B.1
Kohler, M.2
Schulte, U.3
Liu, J.4
Nketiah, E.O.5
Thomas, A.6
Schmalhofer, W.7
Williams, B.8
Bildl, W.9
McMasters, D.R.10
Dai, K.11
Beers, L.12
McCann, M.E.13
Kaczorowski, G.J.14
Garcia, M.L.15
-
40
-
-
37249070254
-
Characterization of a new class of potent inhibitors of the voltagegated sodium channel NaV1 7
-
Williams, B. S., Felix, J. P., Priest, B. T., Brochu, R. M., Dai, K., Hoyt, S. B., London, C., Tang, Y. S., Duffy, J. L., Parsons, W. H., Kaczorowski, G. J., and Garcia, M. L. (2007). Characterization of a new class of potent inhibitors of the voltagegated sodium channel NaV1.7. Biochemistry 46, 14693-14703.
-
(2007)
Biochemistry
, vol.46
, pp. 14693-14703
-
-
Williams, B.S.1
Felix, J.P.2
Priest, B.T.3
Brochu, R.M.4
Dai, K.5
Hoyt, S.B.6
London, C.7
Tang, Y.S.8
Duffy, J.L.9
Parsons, W.H.10
Kaczorowski, G.J.11
Garcia, M.L.12
|